MD Support logo - The Eyes of the Macular Degeneration Community
Reverse background color Reverse background color

Site Search:

Menu

Donate now through Network for Good

Valid XHTML 1.0 Strict.

Latest News from MD Support

Enter your email address
to receive notice when news happens:


new item Nutrition: Separating Fact From Fiction

The November session of the International MD Support Group stressed the advantages of a good diet as the first line of defense against AMD. Ellen Troyer, CEO of Biosyntrx, Inc., a leading manufacturer of dietary products, talked straight about the myths and misunderstandings about proper intake of food and supplements. The program was webcast live on November 12 from the annual meeting of the American Academy of Optometry in Orlando, Florida.

A recording of the audio/visual presentation, titled "Nutrition: Separating Fact From Fiction," is now available for free access from the MD Support Audio/Visual Library.

More than 210 groups worldwide are now affiliated with the IMDSG and taking advantage of its free programs and services. For information about affiliating an existing group or starting a new one with the help of MD Support, select this link.


Brachytherapy May Reduce Burden of Treatment and Further Improve Visual Acuity

A study examines the epimacular brachytherapy procedure when used in patients that require chronic anti-VEGF treatment for wet AMD. More . . .


Blue Light Filtering IOLs May Slow AMD

A 2009 study has shown that implantation of a blue light-filtering intraocular lens (IOL) at the time of cataract surgery increases macular pigment in the retina. More . . .


News from the American Academy of Ophthalmology

MD Support was represented at the annual meeting of the American Academy of Ophthalmology in San Francisco during the last week of October. Abstracts and summaries of all AMD-related posters, papers, and sessions presented at the meeting are now online in the MD Support Library.

MD Support Director Dan Roberts reports that the most numerous developments have recently been in pharmacology, but promising work is also being done in the fields of nutrition, surgery, genetics and low vision rehabilitation. "We are in a holding pattern, with many clinical trials now underway," said Roberts. "We look forward to some exciting breakthroughs during the next next couple of years, as those trials begin to bear fruit."


Image of the cover of 'The First Year: Age-Related Macular Degeneration' By Dan Roberts

"The First Year: Age-Related Macular Degeneration"
An essential guide for the newly-diagnosed and anyone else affected by diseases leading to central vision loss.

Order from Amazon

Learn more